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doi:10.1016/j.gmbhs.2012.04.005Abstract Colorectal cancer (CRC) has high recurrence rate.Effective biomarkers for the
detection of colon cancer are still unavailable. MicroRNA (miRNA) is an epigenetic factor that
regulates cell proliferation, tumor cell growth, cancer formation, and metastasis by regulating
tumor suppressor genes or oncogenes. miRNA has the potential to be used as a biomarker for
the diagnosis of diverse cancers. Previously, we revealed that miR-139-3 p is downregulated
and miR-338-5 p is upregulated in recurrent CRC patients. The present study further reveals
that the miR-139-3 p expression level is inversely correlated with increased metastatic status
in three colon cancer cell lines (SW480, SW620, and colo201), as determined using real-time
polymerase chain reaction. Furthermore, in 51 pairs of CRC clinical specimens, the expression
level of mir-139-3 p was significantly lower in the tumor sections than in the adjacent normal
tissues (p < 0.0001), indicating that they are tumor-suppressive miRNAs. Furthermore, the
expression level of mir-338-5 p in the tumor tissues of metastatic patients was significantly
higher than in the tumor tissues of nonmetastatic patients (p < 0.05), indicating that mir-
338-5 p is positively correlated with metastasis. All together, mir-139-3 p and mir-338-5 pof Microbiology and Immunology, College of Medicine, National Cheng Kung University, # 1 University
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Colorectal cancer (CRC) has been reported in the colon,
rectum, and vermiform appendix. Among human cancers,
9.7% are classified as CRC, which caused 8% of the world-
wide cancer-related deaths in 2008.1 In Taiwan, CRC ranks
as the third deadliest of all cancers and caused 11.4% of
cancer-related deaths in 2010. Effective molecule
biomarkers for the detection of colon cancer are still not
available. Recently, small regulatory RNA, or microRNAs
(miRNAs), have demonstrated the features of tumor
suppressor genes and various tumor oncogenes have been
widely reported.2e5 MiRNA let-7 downregulates RAS onco-
gene protein expression and suppresses lung cancer
formation.2 In contrast, mir-21 promotes breast cancer
transformation by suppressing the expression of the target
gene Pdcd4.3 Furthermore, miR-373 and miR-520c promote
tumor invasion and metastasis of breast cancer.4 In colo-
rectal cancer, miR-451 is a novel candidate that can
circumvent recurrence.5 However, the mechanism that
allows miRNA to regulate colorectal cancer formation
remains unclear. The specific aims of this study are to
evaluate the specificity, sensitivity, and accuracy of
potential miRNAs for the diagnosis of recurrence and
metastasis of CRC using colon cancer cell lines and clinical
colon cancer specimens.Materials and methods
Fifty-one pairs of colorectal cancer specimens (tumor and
adjacent normal tissues), including Dukes stage AeD CRC
specimens (stage A: 3 pairs; stage B: 12 pairs; stage C: 23
pairs; stage D: 13 pairs) were collected at National Cheng
Kung University Hospital, Tainan, Taiwan. These CRC
specimens consisted of 13 pairs of tissues obtained from
metastatic patients and 38 pairs of tissues obtained from
nonmetastatic patients. The colon cancer cell lines SW480
and SW620 cells were cultured in L15 medium (Invitrogen,
Carlsbas, CA, USA), colo205 cells were cultured in RPMI-
1640 medium (Invitrogen) at 37 C in a 5% CO2 incubator.
The SW480, SW620, and colo205 cell lines were collected
with Duke B, C and D patients respectively. In this study,
the RNA of the CRC patient specimens and cell lines was
extracted using TRIzol reagent (MDBio Inc., Taipei,
Taiwan). MicroRNA reverse transcription was conducted
using the Ncode VILO mirRNA cDNA Synthesis kit (Invi-
trogen), and the products were incubated at 37 C for 60
minutes. The expression levels of miR-139-3 p and miR-338-
5 p were measured using SYBR Green supermix (Application
Biosystems, Birchwood, Warrington, UK) by real-time
polymerase chain reaction (PCR). The expression values
were calculated using the comparative Ct method (2-DDCt).Data were compared by using analysis of variance (ANOVA)
and the Student t test.
Results
The CRC cell line data show that mir-139-3 p expression in
SW480 cells (Dukes B, nonmetastatic) is higher than in
SW620 cells (Dukes C, lowly metastatic) (p Z 0.0316) and
colo205 cells (Dukes D, highly metastatic) (p Z 0.0053).
Data obtained from CRC clinical specimens show that the
expression level of mir-139-3 p RNA in CRC tumor sections is
lower than in normal tissues (p < 0.0001). Our data indicate
that mir-139-3 p is negatively correlated with the stage and
metastatic status of the CRC cells.
mir-338-5 p expression in Dukes A stage CRC tumor tissue
was lower than in Dukes B stage tumor tissue (pZ 0.0371).
Furthermore, the expression level of mir-338-5 p in meta-
static patients was higher than in nonmetastatic patients
(pZ 0.0341). Altogether, these data indicate that mir-338-
5 p is positively correlated with CRC metastasis.
Discussion and conclusion
Our results suggest that mir-139-3 p is a tumor-suppressive
miRNA and has no effect on CRC metastasis. Our results are
different from the report by Lin et al, which concluded that
mir-139-3 p is upregulated in CRC with liver metastasis.6 In
conclusion, mir-139-3 p and mir-338-5 p may have potential
uses as biomarkers for the diagnosis of CRC patients at
various stages of cancer. Furthermore, mir-338-5 p may
have potential use for the diagnosis of metastasis in CRC
patients. Additional CRC specimens in late stages, including
metastatic stages, are needed to further clarify the roles of
these two miRNAs during the progression of CRC.
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